New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
07:40 EDTINSY, ESRXInsys valuation could be $4 lower on Subsys exclusion, says Wells Fargo
After another research firm stated that Insys' (INSY) Subsys would be placed on Express Scripts' (ESRX) list of excluded drugs, Wells Fargo estimates that such a development could reduce Insys' valuation by about $4. The firm notes that the stock fell $4.16 on July 31 and August 1. It keeps an Outperform rating on the shares.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
15:09 EDTINSYInsys falls after SIRF links drug to 'growing number' of deaths
Subscribe for More Information
April 23, 2015
13:16 EDTESRXPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTESRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
07:17 EDTINSYInsys Therapeutics commences dosing in Phase 1/2 study of CBD oral solution
Subscribe for More Information
April 17, 2015
10:07 EDTINSYHigh option volume stocks
Subscribe for More Information
April 15, 2015
11:51 EDTESRXExpress Scripts down 2% as Walgreens speaks at analyst day
Subscribe for More Information
April 14, 2015
14:47 EDTINSYInsys Therapeutics management to meet with Jefferies
Meetings to be held in Denver/San Francisco on April 16-17 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use